Literature DB >> 6115322

Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors.

J C Van Meel, A de Jonge, H O Kalkman, B Wilffert, P B Timmermans, P A van Zwieten.   

Abstract

The influence of various calcium antagonists and divalent metal cations on the pressor responses induced by the selective alpha 1-adrenoceptor agonist methoxamine and the selective alpha 2-adrenoceptor stimulating agent B-HT 920 (2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]-azepine) was studied in pithed rats. 1. The calcium antagonists verapamil, D 600 and nifedipine, when given intraarterially (i.a.) in doses up to 1 mg/kg did not influence the pressor effects of methoxamine. Only higher amounts of these calcium antagonistic drugs (1 - 3 mg/kg i.a.) somewhat reduced this pressor response. 2. The vasoconstriction due to B-HT 920, as reflected by the increase in diastolic pressure, was markedly inhibited by verapamil, D 600 and nifedipine in a dose-dependent manner. In low doses a parallel displacement to the right was observed, whereas in higher amounts the shift was non-parallel. 3. The divalent cations MN2+, Ni2+ and Co2+ (0.05 - 0.15 mmol/kg i.a.) hardly affected the pressor effect of methoxamine, whereas B-HT 920-induced vasoconstriction was highly sensitive to these metal ions. La3+ and Mg2+ were ineffective. 4. The calcium antagonists verapamil, D 600 and nifedipine displayed only minor affinities for [3H]prazosin (alpha 1) as well as [3H]clonidine (alpha 2) binding sites of rat brain membranes. 5. It is concluded that an influx of extracellular Ca2+ is necessary for the vasoconstriction in vivo initiated by stimulation of vascular postsynaptic alpha 2-adrenoceptors. On the other hand, vasopressor responses to alpha 1-adrenoceptor stimulation are not directly dependent on a transmembrane influx of calcium ions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115322     DOI: 10.1007/bf00501359

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

Review 1.  Subclassification of alpha-adrenergic receptors by direct binding studies.

Authors:  C L Wood; C D Arnett; W R Clarke; B S Tsai; R J Lefkowitz
Journal:  Biochem Pharmacol       Date:  1979-04-15       Impact factor: 5.858

Review 2.  The role of calcium in the action of drugs on vascular smooth muscle.

Authors:  T Godfraind; A Kaba
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-04

3.  Magnesium and contraction of arterial smooth muscle.

Authors:  B M Altura; B T Altura
Journal:  Microvasc Res       Date:  1974-03       Impact factor: 3.514

4.  Calcium movement in vascular smooth muscle and its detection using lanthanum as a tool.

Authors:  D J Freeman; E E Daniel
Journal:  Can J Physiol Pharmacol       Date:  1973-12       Impact factor: 2.273

5.  Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium.

Authors:  J C Van Meel; A De Jonge; H O Kalkman; B Wilffert; P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1981-01-16       Impact factor: 4.432

6.  Investigation into different types of post- and presynaptic alpha-adrenoceptors at cardiovascular sites in rats.

Authors:  W Kobinger; L Pichler
Journal:  Eur J Pharmacol       Date:  1980-08-08       Impact factor: 4.432

7.  Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle.

Authors:  P D Turlapaty; B M Altura
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

8.  Effects of lanthanum on 45 Ca movements and on contractions induced by norepinephrine, histamine and potassium in vascular smooth muscle.

Authors:  F R Goodman; G B Weiss
Journal:  J Pharmacol Exp Ther       Date:  1971-05       Impact factor: 4.030

9.  Binding of an imidazolidine (clonidine), an oxazoloazepin (B-HT 933) and a thiazoloazepin (B-HT 920) to rat brain alpha-adrenoceptors and relation to cardiovascular effects.

Authors:  R Hammer; W Kobinger; L Pichler
Journal:  Eur J Pharmacol       Date:  1980-04-04       Impact factor: 4.432

10.  Vascular Smooth Muscle: Dual Effect of Calcium.

Authors:  D F Bohr
Journal:  Science       Date:  1963-02-15       Impact factor: 47.728

View more
  22 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Effect of calcium entry blockers on blood pressure and vasoconstrictor responses to alpha-1 adrenoceptor stimulation in conscious spontaneously hypertensive rats.

Authors:  M J Thoolen; C R Miller; A T Chiu; P B Timmermans
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

3.  Alpha 2-adrenoceptor agonists enhance vasoconstrictor responses to alpha 1-adrenoceptor agonists in the rat tail artery by increasing the influx of Ca2+.

Authors:  X H Xiao; M J Rand
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

4.  Influence of calcium entry blockade on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of hypertensive patients.

Authors:  K Jie; P van Brummelen; P Vermey; P B Timmermans; P A van Zwieten
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The inhibition of alpha 1-adrenoceptor-mediated contractions of rabbit pulmonary artery by Ca2+-withdrawal, pertussis toxin and N-ethylmaleimide is dependent on agonist intrinsic efficacy.

Authors:  S Liebau; J Hohlfeld; U Förstermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

6.  Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.

Authors:  R E Buckingham
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

7.  Interactions between the putative calcium entry promotor Bay k 8644 and pressor responses produced by alpha 1- and alpha 2-adrenoceptor agonists in the pithed normotensive rat.

Authors:  B Wilffert; P N van Heiningen; M J Mathy; A de Jonge; M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

8.  B-HT 920 acts as an alpha 1-adrenoceptor agonist in the rabbit aorta under certain in vitro conditions.

Authors:  I Lues; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

9.  Differential effect of calcium entry blockers on alpha 1-adrenoceptor-mediated vasoconstriction in vivo.

Authors:  P B Timmermans; M J Mathy; B Wilffert; H O Kalkman; M J Thoolen; A de Jonge; J C van Meel; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

10.  Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced contractions, adrenergic transmitter release, and alpha-adrenoceptor binding in the female rabbit urethra.

Authors:  B Larsson; E D Högestätt; A Mattiasson; K E Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.